Congestive Heart Failure (Heart Failure) Global Clinical Trials Review, H1, 2019

GlobalData's clinical trial report, “Congestive Heart Failure (Heart Failure) Global Clinical Trials Review, H1, 2019" provides an overview of Congestive Heart Failure (Heart Failure) clinical trials scenario. This report provides top line data relating to the clinical trials on Congestive Heart Failure (Heart Failure). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

– The report provides a snapshot of the global clinical trials landscape

– Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status

– The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company

– The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment

– The Report provides enrollment trends for the past five years

– Report provides latest news for the past three months

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

Assists in formulating key business strategies with regards to investment

Helps in identifying prominent locations for conducting clinical trials which saves time and cost

Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities

Supports understanding of trials count and enrollment trends by country in global therapeutics market

Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials

Facilitates clinical trial assessment of the indication on a global, regional and country level

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Companies mentioned

Novartis AG

Bayer AG

AstraZeneca Plc

Otsuka Holdings Co Ltd

Johnson & Johnson

Amgen Inc

GlaxoSmithKline Plc

Pfizer Inc

Les Laboratoires Servier SAS

Bristol-Myers Squibb ...

Novartis AG

Bayer AG

AstraZeneca Plc

Otsuka Holdings Co Ltd

Johnson & Johnson

Amgen Inc

GlaxoSmithKline Plc

Pfizer Inc

Les Laboratoires Servier SAS

Bristol-Myers Squibb Co

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 5

Report Guidance 6

GlobalData Clinical Trials Report Coverage 7

Clinical Trials by Region ...

Table of Contents 2

List of Tables 4

List of Figures 5

Report Guidance 6

GlobalData Clinical Trials Report Coverage 7

Clinical Trials by Region 8

Clinical Trials and Average Enrollment by Country 9

Top Five Countries Contributing to Clinical Trials in Asia-Pacific 12

Top Five Countries Contributing to Clinical Trials in Europe 13

Top Countries Contributing to Clinical Trials in North America 14

Top Five Countries Contributing to Clinical Trials in Middle East and Africa 15

Top Five Countries Contributing to Clinical Trials in Central and South America 16

Clinical Trials by G7 Countries: Proportion of Congestive Heart Failure (Heart Failure) to Cardiovascular Clinical Trials 17

Clinical Trials by Phase in G7 Countries 19

Clinical Trials in G7 Countries by Trial Status 20

Clinical Trials by E7 Countries: Proportion of Congestive Heart Failure (Heart Failure) to Cardiovascular Clinical Trials 22

Clinical Trials by Phase in E7 Countries 24

Clinical Trials in E7 Countries by Trial Status 25

Clinical Trials by Phase 27

In Progress Trials by Phase 28

Clinical Trials by Trial Status 29

Clinical Trials by End Point Status 31

Subjects Recruited Over a Period of Time 32

Clinical Trials by Sponsor Type 33

Prominent Sponsors 34

Top Companies Participating in Congestive Heart Failure (Heart Failure) Therapeutics Clinical Trials 36

Prominent Drugs 38

Latest Clinical Trials News on Congestive Heart Failure (Heart Failure) 40

Apr 18, 2019: Mount Sinai researchers discover that Diabetes drug may reverse Heart Failure 40

Apr 17, 2019: Quantum Genomics receives first regulatory and ethics approvals to initiate Phase IIb QUORUM study of Firibastat in Heart Failure 40

Apr 09, 2019: New Study Deepens Research Into the Potential Cardiovascular Health Benefits of Supplementation with Nicotinamide Riboside (NR) 40

Apr 01, 2019: Resverlogix cognition substudy of the BETonMACE Phase 3 cardiovascular trial presented at the International Conference on Alzheimer’s & Parkinson’s Diseases 41

Mar 14, 2019: Novartis joins the Global Chagas Disease Coalition and also announces first multinational, prospective, randomized study in people with chronic Chagas cardiomyopathy 41

Mar 11, 2019: Tenax Therapeutics enrolls first patient for phase 2 pulmonary hypertension clinical trial 42

Feb 20, 2019: Cytokinetics announces initiation of phase 1 clinical study of AMG 594, a Cardiac Troponin Activator 42

Feb 06, 2019: Quantum Genomics announces the publication of two scientific articles confirming the efficacy of Firibastat for heart failure 43

Jan 31, 2019: Quantum Genomics presents its 2019 corporate action plan 43

Clinical Trial Profile Snapshots 45

Appendix 1497

Abbreviations 1497

Definitions 1497

Research Methodology 1498

Secondary Research 1498

About GlobalData 1499

Contact Us 1499

Source 1500

List of Tables

Congestive Heart Failure (Heart Failure) Therapeutics, Global, Clinical Trials by Region, 2019* 8

Congestive Heart Failure (Heart Failure) Therapeutics, Global, Clinical Trials and Average Enrollment ...

Congestive Heart Failure (Heart Failure) Therapeutics, Global, Clinical Trials by Region, 2019* 8

Congestive Heart Failure (Heart Failure) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2019* 9

Congestive Heart Failure (Heart Failure) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2019* 11

Congestive Heart Failure (Heart Failure) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2019* 12

Congestive Heart Failure (Heart Failure) Therapeutics Clinical Trials, Europe, Top Five Countries, 2019* 13

Congestive Heart Failure (Heart Failure) Therapeutics Clinical Trials, North America, Top Countries, 2019* 14

Congestive Heart Failure (Heart Failure) Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2019* 15

Congestive Heart Failure (Heart Failure) Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2019* 16

Proportion of Congestive Heart Failure (Heart Failure) to Cardiovascular Clinical Trials, G7 Countries (%), 2019* 17

Congestive Heart Failure (Heart Failure) Therapeutics, G7 Countries, Clinical Trials by Phase, 2019* 19

Congestive Heart Failure (Heart Failure) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2019* 20

Proportion of Congestive Heart Failure (Heart Failure) to Cardiovascular Clinical Trials, E7 Countries (%), 2019* 22

Congestive Heart Failure (Heart Failure) Therapeutics, E7 Countries, Clinical Trials by Phase, 2019* 24

Congestive Heart Failure (Heart Failure) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2019* 25

Congestive Heart Failure (Heart Failure) Therapeutics, Global, Clinical Trials by Phase, 2019* 27

Congestive Heart Failure (Heart Failure) Therapeutics, Global, Clinical Trials In Progress by Phase 2019* 28

Congestive Heart Failure (Heart Failure) Therapeutics, Global, Clinical Trials by Trial Status, 2019* 29

Congestive Heart Failure (Heart Failure) Therapeutics Clinical Trials, Global, by End Point Status, 2019* 31

Congestive Heart Failure (Heart Failure) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2014-2018 32

Congestive Heart Failure (Heart Failure) Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2019* 33

Congestive Heart Failure (Heart Failure) Therapeutics Clinical Trials, Global, Key Sponsors, 2019* 34

Congestive Heart Failure (Heart Failure) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2019* 36

Congestive Heart Failure (Heart Failure) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2019* 38

List of Figures

Congestive Heart Failure (Heart Failure) Therapeutics, Global, Clinical Trials by Region (%), 2019* 8

Congestive Heart Failure (Heart Failure) Therapeutics, Global, Clinical Trials and Average Enrollment ...

Congestive Heart Failure (Heart Failure) Therapeutics, Global, Clinical Trials by Region (%), 2019* 8

Congestive Heart Failure (Heart Failure) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2019* 9

Congestive Heart Failure (Heart Failure) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2019* 11

Congestive Heart Failure (Heart Failure) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2019* 12

Congestive Heart Failure (Heart Failure) Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2019* 13

Congestive Heart Failure (Heart Failure) Therapeutics Clinical Trials, North America, Top Countries (%), 2019* 14

Congestive Heart Failure (Heart Failure) Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2019* 15

Congestive Heart Failure (Heart Failure) Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2019* 16

Proportion of Congestive Heart Failure (Heart Failure) to Cardiovascular Clinical Trials, G7 Countries (%), 2019* 17

Congestive Heart Failure (Heart Failure) Therapeutics, G7 Countries, Clinical Trials by Phase, 2019* 19

Congestive Heart Failure (Heart Failure) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2019* 20

Proportion of Congestive Heart Failure (Heart Failure) to Cardiovascular Clinical Trials, E7 Countries (%), 2019* 22

Congestive Heart Failure (Heart Failure) Therapeutics, E7 Countries, Clinical Trials by Phase, 2019* 24

Congestive Heart Failure (Heart Failure) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2019* 25

Congestive Heart Failure (Heart Failure) Therapeutics, Global, Clinical Trials by Phase (%), 2019* 27

Congestive Heart Failure (Heart Failure) Therapeutics, Global, Clinical Trials In Progress by Phase, 2019* 28

Congestive Heart Failure (Heart Failure) Therapeutics, Global, Clinical Trials by Trial Status, 2019* 29

Congestive Heart Failure (Heart Failure) Therapeutics Clinical Trials, Global, by End Point Status, 2019* 31

Congestive Heart Failure (Heart Failure) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2014-2018 32

Congestive Heart Failure (Heart Failure) Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2019* 33

Congestive Heart Failure (Heart Failure) Therapeutics Clinical Trials, Global, Key Sponsors, 2019* 34

Congestive Heart Failure (Heart Failure) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2019* 36

Congestive Heart Failure (Heart Failure) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2019* 38

GlobalData Methodology 1498

    Pricing

Discounts available for multiple report purchases.

reportstore@globaldata.com
+44 (0) 161 359 5813

Join our mailing list

Saved reports